Plasma Metabolites–Based Prediction in Cardiac Surgery–Associated Acute Kidney Injury

Background Cardiac surgery–associated acute kidney injury (CSA‐AKI) is a common postoperative complication following cardiac surgery. Currently, there are no reliable methods for the early prediction of CSA‐AKI in hospitalized patients. This study developed and evaluated the diagnostic use of metabo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hao Cui, Songren Shu, Yuan Li, Xin Yan, Xiao Chen, Zujun Chen, Yuxuan Hu, Yuan Chang, Zhenliang Hu, Xin Wang, Jiangping Song
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Acceso en línea:https://doaj.org/article/c668b64051d444ba993327462db7c5e4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c668b64051d444ba993327462db7c5e4
record_format dspace
spelling oai:doaj.org-article:c668b64051d444ba993327462db7c5e42021-11-16T10:22:43ZPlasma Metabolites–Based Prediction in Cardiac Surgery–Associated Acute Kidney Injury10.1161/JAHA.121.0218252047-9980https://doaj.org/article/c668b64051d444ba993327462db7c5e42021-11-01T00:00:00Zhttps://www.ahajournals.org/doi/10.1161/JAHA.121.021825https://doaj.org/toc/2047-9980Background Cardiac surgery–associated acute kidney injury (CSA‐AKI) is a common postoperative complication following cardiac surgery. Currently, there are no reliable methods for the early prediction of CSA‐AKI in hospitalized patients. This study developed and evaluated the diagnostic use of metabolomics‐based biomarkers in patients with CSA‐AKI. Methods and Results A total of 214 individuals (122 patients with acute kidney injury [AKI], 92 patients without AKI as controls) were enrolled in this study. Plasma samples were analyzed by liquid chromatography tandem mass spectrometry using untargeted and targeted metabolomic approaches. Time‐dependent effects of selected metabolites were investigated in an AKI swine model. Multiple machine learning algorithms were used to identify plasma metabolites positively associated with CSA‐AKI. Metabolomic analyses from plasma samples taken within 24 hours following cardiac surgery were useful for distinguishing patients with AKI from controls without AKI. Gluconic acid, fumaric acid, and pseudouridine were significantly upregulated in patients with AKI. A random forest model constructed with selected clinical parameters and metabolites exhibited excellent discriminative ability (area under curve, 0.939; 95% CI, 0.879–0.998). In the AKI swine model, plasma levels of the 3 discriminating metabolites increased in a time‐dependent manner (R2, 0.480–0.945). Use of this AKI predictive model was then confirmed in the validation cohort (area under curve, 0.972; 95% CI, 0.947–0.996). The predictive model remained robust when tested in a subset of patients with early‐stage AKI in the validation cohort (area under curve, 0.943; 95% CI, 0.883–1.000). Conclusions High‐resolution metabolomics is sufficiently powerful for developing novel biomarkers. Plasma levels of 3 metabolites were useful for the early identification of CSA‐AKI.Hao CuiSongren ShuYuan LiXin YanXiao ChenZujun ChenYuxuan HuYuan ChangZhenliang HuXin WangJiangping SongWileyarticleacute kidney injurybiomarkerscardiac surgerymachine learningmetabolomicsDiseases of the circulatory (Cardiovascular) systemRC666-701ENJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 22 (2021)
institution DOAJ
collection DOAJ
language EN
topic acute kidney injury
biomarkers
cardiac surgery
machine learning
metabolomics
Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle acute kidney injury
biomarkers
cardiac surgery
machine learning
metabolomics
Diseases of the circulatory (Cardiovascular) system
RC666-701
Hao Cui
Songren Shu
Yuan Li
Xin Yan
Xiao Chen
Zujun Chen
Yuxuan Hu
Yuan Chang
Zhenliang Hu
Xin Wang
Jiangping Song
Plasma Metabolites–Based Prediction in Cardiac Surgery–Associated Acute Kidney Injury
description Background Cardiac surgery–associated acute kidney injury (CSA‐AKI) is a common postoperative complication following cardiac surgery. Currently, there are no reliable methods for the early prediction of CSA‐AKI in hospitalized patients. This study developed and evaluated the diagnostic use of metabolomics‐based biomarkers in patients with CSA‐AKI. Methods and Results A total of 214 individuals (122 patients with acute kidney injury [AKI], 92 patients without AKI as controls) were enrolled in this study. Plasma samples were analyzed by liquid chromatography tandem mass spectrometry using untargeted and targeted metabolomic approaches. Time‐dependent effects of selected metabolites were investigated in an AKI swine model. Multiple machine learning algorithms were used to identify plasma metabolites positively associated with CSA‐AKI. Metabolomic analyses from plasma samples taken within 24 hours following cardiac surgery were useful for distinguishing patients with AKI from controls without AKI. Gluconic acid, fumaric acid, and pseudouridine were significantly upregulated in patients with AKI. A random forest model constructed with selected clinical parameters and metabolites exhibited excellent discriminative ability (area under curve, 0.939; 95% CI, 0.879–0.998). In the AKI swine model, plasma levels of the 3 discriminating metabolites increased in a time‐dependent manner (R2, 0.480–0.945). Use of this AKI predictive model was then confirmed in the validation cohort (area under curve, 0.972; 95% CI, 0.947–0.996). The predictive model remained robust when tested in a subset of patients with early‐stage AKI in the validation cohort (area under curve, 0.943; 95% CI, 0.883–1.000). Conclusions High‐resolution metabolomics is sufficiently powerful for developing novel biomarkers. Plasma levels of 3 metabolites were useful for the early identification of CSA‐AKI.
format article
author Hao Cui
Songren Shu
Yuan Li
Xin Yan
Xiao Chen
Zujun Chen
Yuxuan Hu
Yuan Chang
Zhenliang Hu
Xin Wang
Jiangping Song
author_facet Hao Cui
Songren Shu
Yuan Li
Xin Yan
Xiao Chen
Zujun Chen
Yuxuan Hu
Yuan Chang
Zhenliang Hu
Xin Wang
Jiangping Song
author_sort Hao Cui
title Plasma Metabolites–Based Prediction in Cardiac Surgery–Associated Acute Kidney Injury
title_short Plasma Metabolites–Based Prediction in Cardiac Surgery–Associated Acute Kidney Injury
title_full Plasma Metabolites–Based Prediction in Cardiac Surgery–Associated Acute Kidney Injury
title_fullStr Plasma Metabolites–Based Prediction in Cardiac Surgery–Associated Acute Kidney Injury
title_full_unstemmed Plasma Metabolites–Based Prediction in Cardiac Surgery–Associated Acute Kidney Injury
title_sort plasma metabolites–based prediction in cardiac surgery–associated acute kidney injury
publisher Wiley
publishDate 2021
url https://doaj.org/article/c668b64051d444ba993327462db7c5e4
work_keys_str_mv AT haocui plasmametabolitesbasedpredictionincardiacsurgeryassociatedacutekidneyinjury
AT songrenshu plasmametabolitesbasedpredictionincardiacsurgeryassociatedacutekidneyinjury
AT yuanli plasmametabolitesbasedpredictionincardiacsurgeryassociatedacutekidneyinjury
AT xinyan plasmametabolitesbasedpredictionincardiacsurgeryassociatedacutekidneyinjury
AT xiaochen plasmametabolitesbasedpredictionincardiacsurgeryassociatedacutekidneyinjury
AT zujunchen plasmametabolitesbasedpredictionincardiacsurgeryassociatedacutekidneyinjury
AT yuxuanhu plasmametabolitesbasedpredictionincardiacsurgeryassociatedacutekidneyinjury
AT yuanchang plasmametabolitesbasedpredictionincardiacsurgeryassociatedacutekidneyinjury
AT zhenlianghu plasmametabolitesbasedpredictionincardiacsurgeryassociatedacutekidneyinjury
AT xinwang plasmametabolitesbasedpredictionincardiacsurgeryassociatedacutekidneyinjury
AT jiangpingsong plasmametabolitesbasedpredictionincardiacsurgeryassociatedacutekidneyinjury
_version_ 1718426573238960128